Camurus: Full Year Report January-December 2015
STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
IPO and start of global Phase III trials for CAM2038
Fourth quarter 2015
ยท Net revenue MSEK 36,3 (144,9).
IPO and start of global Phase III trials for CAM2038
Fourth quarter 2015
ยท Net revenue MSEK 36,3 (144,9).